Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc    MYL   US6285301072

MYLAN INC (MYL)

48
Delayed Quote. Delayed Nasdaq - 04/16 04:00:01 pm
47.21 USD   +2.12%
1d ago MYLAN : Launches First Generic ORTHO EVRA® Patch
2d ago MYLAN : Announces Settlement Agreement for First-to-File Generess® Fe
2d ago MYLAN : Launches Generic Lunesta® Tablets
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/10/2014 04/11/2014 04/14/2014 04/15/2014 04/16/2014 Date
47.07(c) 45.72(c) 46.03(c) 46.23(c) 47.21(c) Last
8 843 524 7 297 398 4 857 313 4 383 826 4 055 353 Volume
-3.09% -2.87% +0.68% +0.43% +2.12% Change
More quotes
Company
Mylan, Inc. is a generic and specialty pharmaceuticals company, through its subsidiaries, which develops, manufactures, markets and distributes pharmaceuticals. The company operates its business through two segments: Generics & Specialty. The Generics segment primarily develops, manufactures, sells... 
Surperformance© rating of Mylan Inc
Trading Rating : Investor Rating :
More about the company
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | MYL | US6285301072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 7 926 M
EBIT 2014 2 065 M
Net income 2014 1 119 M
Debt 2014 5 948 M
Yield 2014 -
Sales 2015 8 498 M
EBIT 2015 2 265 M
Net income 2015 1 432 M
Debt 2015 4 962 M
Yield 2015 -
PER 2014 16,29
PER 2015 13,11
EV / Sales 2014 2,92x
EV / Sales 2015 2,61x
Capitalization 17 194 M
More Financials
Latest news on MYLAN INC
1d ago MYLAN : Launches First Generic ORTHO EVRA® Patch
2d ago MYLAN : Announces Settlement Agreement for First-to-File Generess® Fe
2d ago MYLAN : Launches Generic Lunesta® Tablets
2d ago MYLAN : Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Ver..
6d ago MYLAN : Submission of Matters to a Vote of Security Holders (form 8-K)
6d ago MYLAN : Federal Judge Enforces Settlement Agreement Between Mylan and Endo Regar..
6d ago MYLAN : Sets Date for 1st Quarter 2014 Financial Results Conference Call and Liv..
04/08 MYLAN : Schedules First Quarter 2014 Financial Results Conference Call and Live ..
04/07 MEDA : Statement by the Board of Directors of Meda
04/04 Momentum stocks sink; Nasdaq posts worst day since February
04/04DJMARKET SNAPSHOT : U.S. Stocks Sell Off; Nasdaq Drop Worst In 2 Months
04/04DJMARKET SNAPSHOT : U.S. Stocks Sell Off; Nasdaq Drop Worst In 2 Months
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
Mylan Inc : Income Statement Evolution
More Financials
EPS Revisions
Mylan Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF